Cited by 61Smoking Behavior and CessationPosttraumatic Stress Disorder ResearchSubstance Abuse Treatment and Outcomes

Predictors of lapse in first week of smoking abstinence in PTSD and non-PTSD smokers

Open access
Beckham, J. C., Calhoun, P. S., Dennis, M. F., Wilson, S. M., Dedert, E. A.·2013·Nicotine & Tobacco Research

Abstract

INTRODUCTION: Retrospective research suggests smokers with posttraumatic stress disorder (PTSD) lapse more quickly after their quit date. Ecological momentary assessment (EMA) research is needed to confirm the presence of early smoking lapse in PTSD and form conceptualizations that inform intervention. METHODS: Smokers with (n = 55) and without (n = 52) PTSD completed alarm-prompted EMA of situational and psychiatric variables the week before and after a quit date, and self-initiated EMA following smoking lapses. Blood samples at baseline and on the quit date allowed assessment of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEA(S)). RESULTS: PTSD was related to shorter time to lapse (hazard ratio [HR] = 1.677, 95% CI: 1.106-2.544). Increased smoking abstinence self-efficacy was related to longer time to lapse (HR = 0.608, 95% CI: 0.430-0.860). Analyses of participants' real-time reports revealed that smokers with PTSD were more likely to attribute first-time lapses to negative affect ( = 5.412, p = .020), and trauma reminders (Fisher's exact p = .003**). Finally, the quit date decrease in DHEA(S) was related to shorter time to lapse (HR = 1.009, 95% CI: 1.000-1.018, p < .05). CONCLUSIONS: Results provide evidence of shorter time to first smoking lapse in PTSD, and add to evidence that early lapse occasions are more strongly related to trauma reminders, negative affect, and cravings in smokers with PTSD.

Integrity signals

Registry

Crossref · 10.1093/ntr/nts252

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most PTSD patients reinitiate smoking to alleviate their symptoms.

    “Therefore, most PTSD patients reinitiate smoking to alleviate their symptoms (Beckham et al., 2012).”

    From Nicotine addiction and psychiatric disorders (2015) · cites this paper as Beckham et al., 2012

  • Human studies suggest that smoking may alleviate symptoms associated with anxiety disorders, while nicotine abstinence worsens those symptoms and results in higher rates of reinitiation of smoking.

    “While human studies suggest that smoking may alleviate the symptoms associated with anxiety disorders (Beckham et al., 2005; Feldner et al., 2007; Greenberg et al., 2012; Thorndike et al., 2006), nicotine abstinence worsens those symptoms (Dedert et al., 2011) and results in higher rates of reinitiation of smoking (Beckham et al., 2012; Hapke et al., 2005; Lasser et al., 2000).”

    From Nicotine addiction and psychiatric disorders (2015) · cites this paper as Beckham et al., 2012

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Beckham, J. C., Calhoun, P. S., Dennis, M. F., Wilson, S. M., & Dedert, E. A.
Affiliations
  • Durham VA Medical Center (US)
  • Duke Medical Center (US)
  • Duke University (US)
Venue
Nicotine & Tobacco Research
Published
2012-11-22
Volume
15
Issue
6
Pages
1122-1129
ISSN
  • 1462-2203 (ISSN-L)
  • 1469-994X
OpenAlex
W2319587327
Cited by
61
References
43
Citations by year
2024: 3 · 2023: 5 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 7 · 2015: 15 · 2014: 8 · 2013: 3
FWCI
5.58
Type
journal article
Language
en
Open access
Locations
  • Nicotine & Tobacco Research (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • U.S. Department of Veterans Affairs
  • National Institutes of Health (5k24da016388-10)
  • National Institute on Drug Abuse (K24-DA-016388, R21DA019704, 5K24DA016388)
  • National Cancer Institute (R01CA081595, R21CA128965)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
post-traumatic stress disorder, smoking cessation, smoking relapse, early abstinence, trauma reminders, negative affect, nicotine craving, dehydroepiandrosterone sulfate, dehydroepiandrosterone
MeSH terms
Smoking Prevention, Adolescent, Adult, Aged, Dehydroepiandrosterone, Demography, Female, Humans, Male, Middle Aged, Recurrence, Retrospective Studies, Smoking, Stress Disorders, Post-Traumatic, Time Factors, Case-Control Studies, Smoking Cessation, Dehydroepiandrosterone Sulfate, Self Efficacy, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review